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Abstract
Caliciviruses have a positive strand RNA genome covalently-linked at the 5'-end to a small protein, VPg. This study examined the biochemical
modification of VPg by the ProPol form of the polymerase of human norovirus strain MD145 (GII.4). Recombinant norovirus VPg was shown to
be nucleotidylylated in the presence of Mn2+ by MD145 ProPol. Phosphodiesterase I treatment of the nucleotidylylated VPg released the
incorporated UMP, which was consistent with linkage of RNA to VPg via a phosphodiester bond. Mutagenesis analysis of VPg identified Tyrosine
27 as the target amino acid for this linkage, and suggested that VPg conformation was important for the reaction. Nucleotidylylation was
inefficient in the presence of Mg2+; however the addition of full- and subgenomic-length MD145 RNA transcripts led to a marked enhancement of
the nucleotidylylation efficiency in the presence of this divalent cation. Furthermore, evidence was found for the presence of an RNA element near
the 3'-end of the polyadenylated genome that enhanced the efficiency of nucleotidylylation in the presence of Mg2+.
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Noroviruses (NoV), a major cause of acute gastroenteritis
(Green et al., 2001), are members of the family Caliciviridae.
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doi:10.1016/j.virol.2007.12.028at the 5'-end to a VPg protein, and is polyadenylated at its 3'-
end. The genome is organized into three open reading frames
(ORFs): ORF1, ORF2 and ORF3. ORF1 encodes the 200 kDa
precursor of the nonstructural proteins, and ORF2 and ORF3
encode the major (VP1) and minor (VP2) structural proteins,
respectively (Jiang et al., 1993; Lambden et al., 1993). The
200 kDa polyprotein of human norovirus strain MD145
(belonging to genogroup II.4) is cleaved by the viral proteinase
(Pro) to release both precursors and fully processed viral
proteins with the following gene order: NS1-2 (N-terminal
protein): NS3 (NTPase): NS4 (p20): NS5 (VPg): NS6 (Pro):
NS7 (RNA-dependent RNA polymerase) (Belliot et al., 2003;
Sosnovtsev et al., 2006). The norovirus RNA-dependent RNA
polymerase (RdRp) as well as RdRps from several calicivirus
genomes have been expressed in bacteria as a mature form
(designated Pol) or a ProPol RdRp precursor, purified, and
characterized biochemically (Belliot et al., 2005; Fukushi et al.,
2004; Ng et al., 2004; Rohayem et al., 2006a; Wei et al.,
2001). Polymerase activity was demonstrated by both forms of
norovirus RdRp (Belliot et al., 2005). The initiation of RNA
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reported as primer-dependent in some studies and primer-
independent in others (Belliot et al., 2005; Fukushi et al., 2004;
Lopez Vazquez et al., 2001; Rohayem et al., 2006a; Wei et al.,
2001). Various mechanisms by which initiation might occur in
the absence of an added primer have been proposed. Moreover,
a recent study has shown evidence that the uridylylated VPg
protein may serve as a primer for the initiation of norovirus
RNA synthesis on polyadenylated RNA templates (Rohayem
et al., 2006b).
Studies of the role of the calicivirus VPg in replication and the
nature of its linkage to the viral RNA have focused on feline
calicivirus (FCV, genus Vesivirus) (Dunham et al., 1998; Herbert
et al., 1997; Mitra et al., 2004), Norwalk virus and other human
norovirus strains (genus Norovirus) (Rohayem et al., 2006b),
and rabbit hemorrhagic disease virus (RHDV, genus Lagovirus)
(Machin et al., 2001). Early work showed that genomic RNA
purified from FCVand other vesivirus virions was not infectious
after digestion of the VPg by proteinase K (Herbert et al., 1997),
and it was proposed that the VPg was required for translation
(Daughenbaugh et al., 2003; Goodfellow et al., 2005). Recent
reports provided further evidence for the involvement of the
calicivirus VPg in translation. Human and murine norovirus
recombinant VPg proteins were shown to interact directly with
the eukaryotic initiation factor eIF3 in a yeast two-hybrid system
(Daughenbaugh et al., 2003), and the VPg proteins of both FCV
and noroviruses were shown to interact with the translation
factor eIF4E (Goodfellow et al., 2005). Moreover, certain
translation initiation factor inhibitors, such as 4E-BP1, specific
for eIF4E, could markedly reduce translation efficiency in vitro
for some caliciviruses (Chaudhry et al., 2006).
The discovery that recombinant VPg expressed from RHDV
could be uridylylated by the viral polymerase provided initial
evidence that the calicivirus VPg might also serve a primer
function during RNA replication, similar to that of the picor-
navirus VPg (Machin et al., 2001). As noted above, evidence for
such activity has been reported recently for the norovirus VPg
(Rohayem et al., 2006b). It is assumed that the first step in a
VPg-mediated priming mechanism would be nucleotidylylation
at a specific amino acid residue of the VPg. In RHDV, a tyrosine
residue located at position 21 of the VPg was shown to be
uridylylated in vitro by recombinant Pol in the presence of
Mn2+ in a template-independent manner. Mutagenesis of the
corresponding conserved tyrosine residue (position 24) in the
FCV VPg was lethal for the growth and recovery of the virusFig. 1. MD145 VPg DNA constructs generated for study. (A) The primary deduce
positions 27, 30, 41, 46, 53, 54, and 126 are shown in bold type, and the lysine residue
truncated VPg constructs Δ3-, Δ8- and Δ20-VPg-His is indicated. (B) cDNA clones
His-tag is represented by the black box in the diagram, and is located at the N- or C
tyrosine (e.g., pET-His-Y27A/VPg). Double tyrosine-mutated VPg constructs were d
were designated according to the first amino acid in the truncated VPg (e.g., pET-Δ3
grey box. For the Ulp1 cleavage site, SUMO peptide and VPg amino acids are indica
indicated above. (C) SDS-PAGE analysis of 1 μg bacterially-expressed recombinant
terminal His-tag. The mutated rY27A/VPg (Fig. 1C, lanes 9 and 10) was expressed wi
protein (lane 9) and tag-free rY27A/VPg (lane 10) were resolved by SDS-PAGE. Ulp
weight marker (Mark XII, Invitrogen) is indicated in kDa here and in the following(Mitra et al., 2004). These studies suggest that a conserved
tyrosine residue is the site of nucleotidylylation for the calici-
viruses, but this site has not been identified in the noroviruses.
In this study, we examined biochemical modifications of the
VPg by the ProPol form of the MD145 RdRp in an effort to gain
further insight into the role of the VPg in RNA replication for
the noroviruses. One aim was to determine whether the noro-
virus VPg undergoes nucleotidylylation by the ProPol form of
the viral polymerase and to map the site where this modification
occurs. We showed that the VPg was nucleotidylylated by the
ProPol form of the human norovirus RdRp in a template-
independent manner in the presence of Mn2+, and that the
linkage between the nucleotide and the VPg was covalent. We
identified Tyrosine 27 of the MD145 VPg as the target amino
acid for this activity, and showed that the linkage was
susceptible to treatment with phosphodiesterase. Efficient
nucleotidylylation of the VPg could be achieved in the presence
of Mg2+ cations, but only in the presence of selected poly-
adenylated viral RNA templates. In addition, evidence was
found for an enhancing element in calicivirus RNA that might
function similarly to the cis-acting replication element (CRE) of
the picornaviruses.
Results
Synthesis and purification of recombinant VPg proteins
Recombinant VPg proteins were expressed either as N- or C-
terminal 6× His-tagged fusions, or as proteins without a His-tag
(summarized in Fig. 1B). The VPg proteins with an N-terminal
His-tag were expressed in the pET system and purified on a
nickel-nitrilotriacetic (NTA) column to greater than 85% homo-
geneity (Fig. 1C, lanes 1 to 7). The recombinant proteins rVPg-
His, rΔ3VPg-His, rΔ8VPg-His and rΔ20VPg-His, in which the
His-tag was engineered at the C-terminus, were purified to over
90% homogeneity (Fig. 5A, panel II). The SUMO-VPg
recombinant fusion proteins (rHis-SUMO-VPg, rHis-SUMO-
Y27A/VPg, rHis-SUMO-Y30A/VPg) were purified on a Ni-
NTA column (as shown for rHis-SUMO-Y27A/VPg in Fig. 1C,
lane 9) and then incubated with Ulp1 proteinase. The mixture
was again passed through a Ni-NTA column to bind the cleaved
SUMO-His-tag and the His-tag-free recombinant VPg protein
was collected in the flow-through (as shown for rHis-SUMO-
Y27A/VPg in Fig. 1C, lane 10). The efficiency varied, but at
least 50% of the fusion protein was cleaved with Ulp1 (data notd amino acid sequence of the MD145 VPg is shown. The tyrosine residues at
s in the N-terminal region are underlined. The N-terminus of the VPg encoded in
engineered for expression of the MD145 VPg and its mutated forms in bacteria.
-terminus. The VPg constructs were designated according to the mutagenized
esignated similarly. VPg proteins with sequential deletions from the N-terminus
VPg-His). For the SUMO-VPg constructs, the SUMO peptide is indicated by a
ted by lower and lower cases, respectively. The resulting construct was named as
VPg proteins (lanes 1–7) and Pro–Pol (lane 8) that were engineered with an N-
thout a His-tag (see Materials and methods). The rHis-SUMO-Y27A/VPg fusion
1 proteinase treatment is indicated above the gel. The migration of the molecular
figures.
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a small protein (under 10 kDa) were consistently observed
(Fig. 1C, lane 10). This 10 kDa protein was not present inrecombinant RdRp preparations derived by bacterial expres-
sion, and was not immunoprecipitated using VPg-specific im-
mune serum (Fig. 6C, lanes 3, 5 and 7).
Fig. 2. Nucleotidylylation of rHis-VPg by the rHis-Pro–Pol polymerase.
(A) Two μg of rHis-VPg were assayed in the presence of [α32P]-NTP (either
UTP, lanes 1 and 5; GTP, lane 2; CTP, lane 3 and ATP, lane 4). Lane 5 contains a
negative control without VPg and Mn2+. The NTP used in each assay, and the
presence or absence of VPg and Mn2+(0.5 mM final) is indicated above the gel.
The identities of the radiolabeled proteins are indicated on the right, and the
modified rVPg protein is indicated by an asterisk here and the following figures.
(B) In a separate experiment, guanylylation and uridylylation reactions of rHis-
VPg were conducted in triplicate. Five μl of each assay was analyzed by SDS-
PAGE. Labeled VPg separated by SDS-PAGE, was excised from the gel and the
amount of UMP (black column) and GMP (white column) incorporated into
VPg was determined. The graph represents the mean value of the triplicate assay
for each NTP. Incorporated NMP is given in pmol/μg of rHis-VPg (left side of
the graph). Standard deviations are indicated by vertical bars.
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Our previous studies showed that both Pol and ProPol forms
of the norovirus RdRp are active as a polymerase (2). Because
previous studies had shown that the Pol form of both the RHDV
and norovirus RdRp was able to mediate uridylylation of the
VPg (Machin et al., 2001; Rohayem et al., 2006b), we decided
to investigate whether the ProPol form had this activity. Our
preliminary studies showed that both the Pol and ProPol forms
of the MD145 norovirus RdRp (Belliot et al., 2005) could
uridylylate the MD145 VPg (data not shown). It should be
noted that the distantly-related picornavirus 3CDpro protein,
which is also a precursor containing a proteinase and polymerase
domain, was not active in a VPg nucleotidylylation assay.
However, it was able to stimulate uridylylation by the mature
3Dpol form of the polymerase in the presence of a cis-acting
replication element, or CRE (Paul et al., 2000). A nucleotidy-
lylation reaction was performed in which enzymatically-active
MD145 ProPol (rHis-Pro–Pol) that contained an inactivated
proteinase domain to prevent autocatalytic cleavage (Belliot
et al., 2005), was incubated with purified MD145 VPg (rHis-
VPg) in the presence of each of the [α-P32]-labeled nucleotides
(UTP, GTP, ATP, or CTP) individually andMn2+, as described in
Materials and Methods. Radiolabeling of the recombinant VPg
protein (21 kDa) was observed with each of the four nucleotides
(Fig. 2A, lanes 1–4), with adenylylation appearing least
efficient. An additional radiolabeled band was detected with
an observed mass of 76 kDa, consistent in size with the ProPol
noted above (Fig. 1C, lane 10). A similar radiolabeling of the
poliovirus 3D pol has been observed in VPg uridylylation
reactions, but it is not clear whether this auto-uridylylation of
3Dpol is essential for replication (Richards et al., 2006). A
radiolabeled 10 kDa band was also observed in some
experiments. This small protein, noted above, was likely a
bacterial protein that co-purified with the recombinant VPg or a
VPg degradation product. The amount of radioactivity incorpo-
rated into the guanylylated and uridylylated 21 kDa forms of the
VPg protein was determined as described in the Materials and
Methods. The guanylylation reaction was found to be ap-
proximately two times more efficient than the uridylylation
reaction under these conditions (Fig. 2B). The ability of the
MD145 ProPol to utilize all four NTPs in the modification of
VPg was similar to that reported previously for RHDV Pol
(Machin et al., 2001).
We next established the minimal requirements for the nu-
cleotidylylation reaction. As noted above, the uridylylation
reaction resulted in the production of three major radiolabeled
products (Fig. 3A, lanes 1 and 4). The recombinant VPg protein
(21 kDa) was not radiolabeled in the absence of Mn2+ (Fig. 3A,
lane 2) or rHis-Pro–Pol (Fig. 3A, lane 3), or when incubated
with heat-inactivated rHis-Pro–Pol (Fig. 3A, lane 5). These data
suggested that the modification of the VPg was associated with
an active polymerase, and required a divalent cation. The
observed efficiency of the VPg nucleotidylylation was similar
in the presence of 0.5 to 1 mM MnCl2 (data not shown). No
radiolabeled VPg was observed when rHis-Pro–Pol was re-placed by rHis-Pro–, indicating that the Pol domain of the
ProPol polymerase was responsible for the activity (Fig. 3A,
lane 6).
Various enzymatic treatments of the radiolabeled VPg pro-
tein were performed to examine the biochemical nature of the
VPg modification. Treatment of the radiolabeled VPg with
proteinase K abolished the detection of radiolabeled protein, as
expected (compare Fig. 3B, lanes 1 and 5). Coomassie blue
staining of the proteins in the corresponding gel confirmed
proteolytic degradation of the VPg (data not shown). Treatment
of the radiolabeled VPg with calf intestinal alkaline phosphatase
Fig. 3. Characterization of the VPg modification by ProPol. (A) Autoradiography of the VPg-uridylylation assay. Two μg of rHis-VPg was incubated in the presence of
[α32P]-UTP and several combinations of rHis-Pro–Pol (1 μg), rHis-Pro− (1 μg) and Mn2+ as indicated above the gel. rHis-Pro–Pol was also heated at 65 °C for 10 min
prior to addition to the assay (lane 5). (B) Autoradiography of the UTP-labeled VPg after enzymatic treatment. Uridylylation assay and enzymatic treatments are
described in the Materials and methods. The 15 μl reaction was Proteinase K- or RNase-treated (lanes 1 and 3). The 15 μl reaction was also CIAP-treated
(Calf Intestinal Alkaline Phosphatase, lane 4) or CIAP- and RNase-treated (lane 2). Enzymatic treatments are indicated above the gel. For the control (lane 5), 5 μl of
the uridylylation assay were directly resolved by SDS-PAGE. (C) Nuclease P1 and phosphodiesterase 1 (PDE1) treatment of the uridylylated VPg. For the control
(lane 1), 5 μl of the assay was directly resolved by SDS-PAGE. Enzymatic treatments are indicated above the gel. The insert contains a magnified view of the labeled
VPg from lane 1 (lane 1a) and 2 (lane 2a). The putative forms of labeled VPg are indicated by arrows (VPg-pUpU and VPg-pU) or bracket (VPg-p(U)n). (D) Two μg of
rHis-VPg were assayed for nucleotidylylation in the presence of [α32P]-GTP (lanes 1, 3 and 4) or [γ32P]-GTP (lane 2). The combinations of VPg, Mn2+(1 mM final),
[α32P]-GTP and [γ32P]-GTP are indicated above the gel. rHis-Pro–Pol and rHis-VPg are indicated by arrows.
37G. Belliot et al. / Virology 374 (2008) 33–49(CIAP) did not abolish the radioactivity (Fig. 3B, lane 4),
suggesting that the modification of the VPg was not due to
phosphorylation. Further treatment of the radiolabeled VPg
with RNase (a mixture of enzymes isolated from bovine
pancreas) and RNase in the presence of CIAP (Fig. 3B, lane 2),
which together would hydrolyze a diverse number of potentialcovalent bonds, resulted in a weaker intensity of the VPg
labeling, presumably by converting VPg-p(U)n to the VPg-pUp
form. A similar product was observed when labeled VPg was
treated only with the RNase mix (Fig. 3B, lane 3). We next
examined the activity of nuclease P1, an enzyme that cleaves 3'-
phosphodiester bonds and 3'-phosphomonoester bonds, leaving
38 G. Belliot et al. / Virology 374 (2008) 33–49a 3'-end hydroxyl group (Fig. 3C, lanes 1 and 2). A magnified
view of the uridylylated VPg after P1 treatment showed the
presence of a doublet presumably composed of VPg-p(U) and
VPg-pUpU, with the latter form consistent with incomplete
processing by the nuclease P1 (Fig. 3C, lanes 1a and 2a). The
intensity of the radiolabeled VPg was reduced but not abol-
ished, suggesting that a radiolabeled UMP moiety remained.
The nuclease P1-treated VPg protein was further incubated
in the presence of phosphodiesterase 1 (PDE1), which can
hydrolyze a 5'-phosphodiester bond in a ribonucleotide with a
free 3'-hydroxyl group (Fig. 3C, lane 3). This treatment caused
a complete loss of radiolabel from the VPg, suggesting that the
VPg was linked to the UMP molecule via a 5'-phosphodiester
bond. The presence of the intact VPg protein in the products of
PDE1 hydrolysis was confirmed by Coomassie blue staining of
protein in the corresponding gel (data not shown).
Because all calicivirus genomes begin with a 5'-end gua-
nosine residue, and it is presumed that the VPg is linked to this
terminal nucleotide, we further examined the nature of the
linkage mediated by ProPol between the norovirus VPg and
GTP in a guanylylation reaction. VPg was labeled when
[α-32P]-GTP was employed in the reaction (Fig. 3D, lane 1), but
not [γ-32P]-GTP (Fig. 3D, lane 2). These data suggest that the
linkage of the norovirus VPg to RNA utilizes an alpha
phosphate group, similar to the picornaviruses, and that NMP
is incorporated. The absence of radiolabeling with [γ-32P]-GTP
is consistent with the phosphatase data above (Fig. 3B), in that a
phosphorylation event was not responsible for the radiolabeling
of the VPg.
Mapping tyrosine at position 27 in the MD145 VPg protein as
the site of nucleotidylylation
Our next experiments addressed the identity of the amino acid
residue in the norovirus VPg that undergoes modification by
nucleotidylylation. A tyrosine residue previously shown to be
conserved among the caliciviruses was identified as the site of
uridylylation by the RHDV polymerase (Machin et al., 2001).
This conserved tyrosine residue is located at position 27 in the
VPg of MD145. A mutagenized VPg protein designated rHis-
Y27A/VPg was engineered in which Tyr 27 was replaced with
alanine. Analysis of the rHis-Y27A/VPg protein in a nucleoti-
dylylation reaction (with UTP) showed a marked reduction in
the intensity of the signal (Fig. 4A, lane 2) compared to that of
the wild type VPg, rHis-VPg (Fig. 4A, lane 1). The faint band
corresponding to rHis-Y27A/VPg (Fig. 4A, lane 2) might be
explained by the labeling of an alternative tyrosine residue, and
we examined this possibility in a series of mutagenesis experi-
ments. The MD145 VPg amino acid sequence contains seven
tyrosine residues (Fig. 1B), and we engineered several additional
modified VPg-mutated proteins in which individual tyrosine
residues were replaced by alanine residues. Recombinant VPg
(rHis-VPg, rHis-Y27A/VPg, rHis-Y30A/VPg, rHis-Y41A/VPg,
rHis-Y46A/VPg, rHis-Y53A/VPg, or rHis-Y54A/VPg) was
assayed for uridylylation, and the relative amount of UMP
incorporated into VPg was measured with a phosphorimager
(Fig. 4B). The mutagenesis of Tyr 27 showed the greatest effect,reducing the signal by approximately 95% compared to the wild
type VPg control. Mutagenesis of Tyr 53 or Tyr 54 reduced the
signal by approximately 60%. Surprisingly, the mutagenesis of
Tyr 30, 41 and 46 resulted in a 6.4-fold, 2-fold, and 2.7-fold
increase in the labeling of VPg, respectively. In order to deter-
mine whether Tyr 27 was the site of enhanced uridylylation
observed in the single tyrosine mutants, we engineered and
tested double tyrosine-mutated VPg proteins (rHis-Y27,30A/
VPg, rHis-Y27,41A/VPg, rHis-Y27,46A/VPg, rHis-Y27,53A/
VPg, rHis-Y27,54A/VPg). In addition, a mutagenized VPg
protein rHis-Y27,30,41,46,53,54A/VPg in which all tyrosine
residues (except for position 126) were replaced with alanine
residues, was also assayed. Analysis of the Tyr 27-mutagenized
VPg proteins in a uridylylation reaction yielded proteins with
signals that were 5 to 12% of that obtained with the wild type
rHis-VPg control (Fig. 4B). This result indicated that the en-
hanced uridylylation observed with the single tyrosinemutations
at positions 30, 41 and 46 was likely due to an increase in the
efficiency of uridylylation at Tyr 27. Taken together, the muta-
genesis studies identified Tyr 27 as the major site of nucleo-
tidylylation in the MD145 VPg.
In order to address whether the recognition of Tyr 27 as the site
of nucleotidylylation might be influenced by the presence of a
His-tag on the VPg protein, we expressed wt VPg (rVPg) and
mutated VPg proteins, rY27A- and rY30A/VPg, in a bacterial
expression system (SUMO) that allowed the purification of native
VPg without a His-tag. Again, the mutagenesis of Tyr 27 in a
native (non-His-tagged) VPg resulted in a marked decrease in the
incorporation of radiolabel in a uridylylation reaction (Fig. 4C,
lane 2) compared to the wt VPg control (Fig. 4C, lane 1). As
observed above, uridylylation of rY30A/VPg (Fig. 4C, lane 3)
was enhanced (Fig. 4D). These data suggested that the His-tag did
not have a major effect on the modification of the VPg, and that
conformation likely plays a role in the presentation of Tyr 27 to
the RdRp. Structural studies of the VPg by X-ray crystallography
should give further insight.
Influence of the N-terminal region of the VPg protein on
nucleotidylylation
A lysine-rich NTP-binding motif (AYTKKGK) in the poty-
virus (potato A virus) VPg was found to play a critical role in
uridylylation (Puustinen and Makinen, 2004). The presence of a
similar lysine-rich region at the N-terminus of the calicivirus
VPg (Fig. 1A) prompted us to examine its role in nucleotidy-
lylation. A series of mutagenized VPg proteins was engineered
in which the first 3, 8, or 20 amino acids were deleted. The
recombinant wt VPg protein and the truncated forms of the VPg
(rΔ3-, rΔ8- and rΔ20-VPg-His) (Fig. 5A, panel I) were assayed
in a guanylylation reaction in the presence of [α-32P]-GTP
(Fig. 5A). The guanylylation of rVPg-His (wt), rΔ3-VPg-His
and rΔ8-VPg-His was observed in the presence of 1 mMMnCl2
and [α-32P]-GTP (Fig. 5A, panel I, lanes 1, 2, and 4, respec-
tively), while rΔ20-VPg-His protein was not radiolabeled
(Fig. 5A, panel I, lane 3). The deletion of 3, 8 and 20 amino
acids at the N-terminus of the VPg protein reduced the amount
of measured radioactivity in the guanylylation reaction by 83,
Fig. 4. Role of the tyrosine residues in VPg uridylylation. (A) The expression and purification of the His-tag-free rPro–Pol has been described previously (Belliot et al.,
2005). 2 μg of rHis-VPg (lane 1) or rHis-Y27A/VPg (lane 2) were incubated in the presence of rPro–Pol, 1 mMMnCl2 and [α
32P]-UTP. Labeled proteins are indicated
by arrows on the right side of the gel. (B) Effect of the tyrosine residues at positions 27, 30, 41, 46, 53 and 54 on the uridylylation of the VPg proteins. The VPg-
mutated proteins are indicated below the graph. rVPg protein (1.5 μg) was incubated with 1 μg of SUMO-expressed rPro–Pol in the presence of 5 μCi [α32P]-UTP and
0.5 mM MnCl2. 5 μl of each reaction were analyzed by SDS-PAGE. The relative amount of incorporated UMP was determined by using a Phosphorimager.
Incorporation values are given in percentage of the level of incorporation for the wt VPg protein (100%). (C) SUMO-expressed wild type (wt, lanes 1 and 4) VPg,
rY27A/VPg (lanes 2 and 5) and rY30A/VPg (lanes 3 and 6) were assayed for uridylylation in the presence of tag-free rPro–Pol, 1 mM MnCl2, and [α
32P]-UTP. Wild
type and mutated VPgs were also heated at 65 °C for 10 min prior to incubation with rPro–Pol (lanes 4 to 6). Uridylylation assays were then conducted the same way.
The proteins of interest are indicated by arrows. (D) Role of the tyrosine residues at positions 27 and 30 in uridylylation. Tag-free-wt rVPg (black column), rY27A/VPg
(white column) and rY30A/VPg (grey column) were assayed for uridylylation in the presence of tag-free rPro–Pol. The uridylylation assays were conducted in
triplicate and 5 μl of each assays were analyzed by SDS-PAGE. The amount of incorporated UMP is given in disintegration per minute (dpm) per microgram of VPg.
Columns represent mean values and standard deviations are represented by vertical bars.
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VPg control (Fig. 5B). It is likely that the N-terminal region of
the VPg may be important in the conformational presentation of
Tyr 27 to the RdRp for nucleotidylylation. Alternatively, the
lysine-rich N-terminus might have NTP-binding properties
similar to the potato A virus (Puustinen and Makinen, 2004).
Additional mutagenesis studies will be needed to map theprecise amino acids in the N-terminus that facilitate nucleoti-
dylylation of the VPg.
Uridylylation of VPg in the presence of poly(A) templates
It was previously shown that uridylylation of the RHDVVPg
by Pol could be achieved in the absence of template RNA
Fig. 5. Deletionalmutagenesis of theN-terminus of the norovirusVPg. (A)Threeμg
of wild type rVPg-His (wt, lane 4), rΔ3-VPg-His (Δ3, lane 1), rΔ8-VPg-His
(Δ8, lane 2) and rΔ20-VPg-His (Δ20, lane 3) were assayed for guanylylation in
the presence of 1 μg of rE1189A/ProPol-His, [α32P]-GTP and 1 mM MnCl2.
Wild type and truncated VPg proteins are indicated above the gel. The
autoradiography and Coomassie blue staining of the modified VPg proteins are
shown on panels I, and II, respectively. Panels I and II represent the same gel.
(B) Amount of incorporated GMP into wt and truncated VPgs. Three μg of wild
type rVPg-His (grey column), rΔ3-VPg-His (Δ3, hatched column), rΔ8-VPg-
His (Δ8, black column) and rΔ20-VPg-His (Δ20, white column) were assayed
for guanylylation as described above. The assays were conducted in triplicate.
The amount of incorporated UMP was calculated as described in Materials and
methods and reported here as pmol/μg of VPg. Columns represent the mean
value of three experiments and the standard deviation is indicated by vertical
bars.
40 G. Belliot et al. / Virology 374 (2008) 33–49(Machin et al., 2001), and our next experiments examined
whether this feature of nucleotidylylation was shared by the
MD145 ProPol. An uridylylation assay was performed in the
presence or absence of a poly(A) template or oligo(U)15 to
determine their effects on the nucleotidylylation of the
MD145 VPg in the presence of Mn2+. A constant amount of
rHis-Pro–Pol (1 μg) was used in each assay, with decreasing
concentrations of rHis-VPg protein (3, 1.5, 0.75 and 0.375 μg/
assay). There was no detectable difference in the profile of uri-
dylylation assays performed in the absence (Fig. 6A, lanes 1–4) or
the presence (Fig. 6A, lanes 9–12) of oligo(U)15. In contrast, in
the presence of a poly(A) template, radiolabeled VPg was
detected at all four concentrations of VPg examined (Fig. 6A,
lanes 5–8). Moreover, a diffuse signal (appearing as a smear on
the autoradiograph) representing radioactive material was
observed near the top of the gel (Fig. 6A, lanes 6–8). Further
analysis showed that this diffuse signal was generated in a
reaction without VPg (Fig. 6B, lane 3), and was sensitive to
RNase treatment (Fig. 6B, lanes 2 and 4). It was likely that this
material represented newly-synthesized poly(U)n products gen-erated by the rHis-Pro–Pol polymerase, which has been reported
to have primer-independent RdRp activity in the presence of
Mn2+ (Belliot et al., 2005; Fukushi et al., 2004). However, in
this experiment, we could not rule out the possibility that a
proportion of the products were poly(A) templates that had
been terminally labeled by the RdRp (Rohayem et al., 2006a).
To examine whether rHis-VPg molecules might be cova-
lently-linked to the newly-synthesized radiolabeled products,
rHis-VPg and rHis-Y27A/VPg were immunoprecipitated by
VPg-specific antibodies from uridylylation assays that included
poly(A)n templates (Fig. 6C, lanes 2–3 and lanes 8–9). The
larger radiolabeled products co-precipitated with both VPg
proteins, including the non-uridylylated VPg with a mutagen-
ized Tyr 27 (Fig. 6C, lane 9). Treatment of the uridylylation
reaction with RNase (Fig. 6C, lanes 4–5 and 10–11) or heat
(65 °C for 15 min) (Fig. 6C, lanes 6 and 7) prior to immuno-
precipitation of the VPg and SDS-PAGE led to the disappear-
ance of the high-MW radiolabeled products, while retaining the
radiolabeled precipitated VPg. In order to verify that the high-
MW products were radiolabeled RNA products, the material
remaining after heat treatment and immunoprecipitation of the
VPg was ethanol-precipitated and analyzed in a denaturing
agarose gel. Autoradiography of the dried gel showed the pre-
sence of radiolabeled material (data not shown). Taken together,
these data suggested that most of the incorporated label in the
uridylylation reaction was not covalently-linked to the uridyly-
lated VPg. In addition, the synthesis of these products could
occur without the involvement of a uridylylated VPg (Fig. 6B,
lane 3). The efficient co-precipitation of these RNA products
with VPg under the conditions of the radioimmunoprecipitation
assay (RIPA) suggested that the VPg binds RNA. Additional
studies will be needed to establish the RNA-binding properties
of VPg and its potential role in replication.
Nucleotidylylation of VPg in the presence of genomic RNA
Uridylylation of the RHDV VPg was shown to be template-
independent and optimal in the presence ofMn2+ divalent cations,
and weak uridylylation of the VPg was observed also in the
presence of Mg2+ (Machin et al., 2001). In contrast, uridylylation
of the poliovirus VPg was shown to be template-dependent in the
presence of Mn2+ (Paul et al., 1998). Moreover, efficient
uridylylation of the poliovirus VPg by 3Dpol in the presence of
Mg2+ was dependent on the presence of a CRE element, and the
reaction was enhanced by the addition of 3CDpro (Paul et al.,
2000). We evaluated whether the addition of various RNA
templates corresponding to the MD145 genome might improve
the efficiency ofVPg nucleotidylylation by ProPol in the presence
of Mg2+. Plasmid constructs containing either full-length or
truncated sequences of the MD145 norovirus genome engineered
immediately downstream of the T7 RNA polymerase promoter
were linearized and used to generate RNA molecules by in vitro
transcription with T7 polymerase (Fig. 7A). Nucleotidylylation
assays were performed similar to those described above, except
that all four NTPs were included in the reaction and Mg2+ was
used as the divalent cation. In addition, we utilized rHis-E1189A/
ProPol (which is similar in RdRp activity to rHis-Pro–Pol, but
Fig. 6. VPg uridylylation in the presence of homopolymeric poly(A)n templates. (A) 3 μg (lanes 1, 5 and 9), 1.5 μg (lanes 2, 6 and 10), 0.75 μg (lanes 3, 7 and 11) and
0.375 μg (lanes 4, 8 and 12) of rHis-VPg (corresponding to 180, 90, 45, and 22.5 pmol/assay, respectively) were assayed for uridylylation in the presence of rHis-
Pro–Pol (13 pmol), [α32P]-UTP and 1 mM MnCl2. Uridylylation assays were also performed in the presence of 5 μg of homopolymeric poly(A)n templates (Roche)
(lanes 5 to 8) or 10 μM oligo(rU)15 primer (Invitrogen) (lanes 9 to 12). The decreasing amounts of rHis-VPg are represented by an open triangle above the gel. The
presence of poly(A)n and oligo(U)15 in each reaction is indicated above the gel. (B) 1 μg of rHis-Pro
–Pol was incubated with 5 μg of poly(A)n, 5 μCi [α
32P]-UTP, and
1 mMMnCl2 in the presence (lanes 1 and 2) or absence (lanes 3 and 4) of 1.5 μg rHis-VPg). 5 μl of each reaction were resolved by SDS-PAGEwithout treatment (lanes
1 and 3) or following treatment with RNase prior to SDS-PAGE (lanes 2 and 4). The combinations of RNase and VPg are indicated above the gel. Labeled poly(U)n
and rHis-VPg are indicated by bracket and arrow, respectively on the right side of the gel. (C) Immunoprecipitation assay of the uridylylation reaction mixture with an
antiserum raised against bacterially-expressed rHis-VPg (Belliot et al., 2003). For each immunoprecipitation assay, a uridylylation assay was first performed with rHis-
Pro–Pol, rHis-VPg (lanes 2 to 7), and rHis-Y27A/VPg (lanes 8 to 11). The reaction mixture was then assayed by immunoprecipitation without treatment (lanes 2, 3, 8
and 9) or following treatment with RNase (lanes 4, 5, 10 and 11) or heating at 65 °C for 10 min (lanes 6 and 7). Labeled materials were resuspended with
electrophoresis lysis buffer, released by boiling and directly resolved in a 12% Tris-glycine polyacrylamide denaturing gel, or used for RIPA. The serum (VPg pre- or
post-immunization) used in each reaction is indicated. The positive control in lane 1 was 5 μl of a VPg-uridylylation assay as described above. Labeled poly(U)n and
rHis-VPg are indicated on the right with a bracket and arrow, respectively.
41G. Belliot et al. / Virology 374 (2008) 33–49containing an active proteinase and a mutagenized cleavage site
between Pro and Pol) so that the bifunctional enzymatic activity
of the precursor protein would remain intact.
First, we examined the uridylylation of VPg by rHis-
E1189A/ProPol in the presence of full-length (FL) genomic
RNA transcripts, with or without oligo(U)15 (Fig. 7B). rVPg-His was successfully uridylylated in the presence of Mg2+ and
genomic RNA (Fig. 7B, lanes 2 and 3 of panel I), and the
addition of oligo(U)15 had little effect. The presence of a non-
viral control RNA template (non-polyadenylated) did not en-
hance uridylylation in the presence of Mg2+ (Fig. 7B, lanes 8
and 9, panel I), and again, mutagenesis of Tyr 27 abolished
42 G. Belliot et al. / Virology 374 (2008) 33–49uridylylation (Fig. 7B, lanes 5 and 6). An immunoprecipitation
assay was performed to confirm the identity of the radiolabeled
protein as VPg (data not shown). These data suggested that
uridylylation of the VPg through Tyr 27 could be achieved in
the presence of Mg2+ and a viral RNA template. As shown
above, radiolabeled RNA co-precipitated with the VPg and
appeared as high-MW products in the gel (Fig. 7B, lanes 2–3,
5–6 and 8–9). We ethanol-precipitated the remaining radio-
labeled RNA products following heating and immunopreci-Fig. 7. Effect of MD145 genomic and subgenomic RNAs on VPg uridylylation in th
genomic organization of theMD145RNAgenome is based upon the sequence availabl
are indicated. pSPORT1-FL/MD145 and pSPORT1-SG/MD145 were linearized by A
upstream of the 5'-end (open triangle) and a 29 nucleotide length polyA tail at the 3'-e
pSPORT1-FL/MD145 plasmid construct was linearized at the NcoI restriction site nat
then used to produce RNA. The cORF1 construct was described previously (linearize
DNA templates, a T7 promoter sequence was engineered into the forward primer, an
pSPORT1-FL/MD145 (above) and pQ14 (Sosnovtsev and Green, 1995) plasmids we
calicivirus PCR products, respectively. (B) VPg uridylylation in the presence of geno
(panels I and II). The gel was Coomassie-stained (panel II), dried and subjected to au
(lanes 4 to 6) used for the assays are indicated above panel I. The uridylylation assay
control RNAwithout a poly(A) tail (Promega) (lanes 7 to 9). Several combination of V
control, rVPg-His was heated at 65 °C for 10 min (lane 10) prior to the uridylylatio
indicated by arrow. (C) Panel I. Wild type rVPg-His (lanes 1 to 7) and rHis-Y27A/V
subgenomicRNA (SG, lanes 1 and 8), ORF1RNA (lanes 2 and 9), genomic RNA lacki
template (lane 5 and 12) or in the absence of any RNA (lanes 6, 7, 13 and 14). For the n
each reaction was analyzed by SDS-PAGE. rVPg-His and rHis-E1189A/ProPol are in
the presence ofMg2+ and RNA transcripts representing subgenomic regions of either n
indicated above the lane and diagrammed in 7A above. A polyadenylated globin mess
viral RNA control (lane 7). The negative control (lane 10) excluded ProPol and temppitation of the uridylylated VPg, and again, the majority of
the radiolabeled RNA was not covalently-linked to the VPg
(data not shown). In order to further examine the association of
VPg with the RNA, we heated the VPg protein at 65 °C for
10 min prior to the uridylylation reaction as a negative control.
Heating the VPg led to loss of its ability to be uridylylated
(Fig. 7B, lane 10, panel I and II), and to associate with the
radiolabeled RNA derived from the FL template RNA (data not
shown), suggesting that conformation was important.e presence of Mg2+. (A) Diagram of the constructs used in the experiment. The
e inGenbank (AY032605). Positions of the first and last nucleotides for eachORF
atII for RNA production. Both constructs were engineered with a T7 promoter
nd (poly(A)29). To generate genomic RNA lacking ORF3 (named FL-NcoI), the
urally present at position 6667 of theMD145 genome. Linearized constructs were
d by NotI for RNA production) (Belliot et al., 2003). For the generation of PCR
d the reverse primer was engineered either with or without a poly(A)29 tail. The
re used as the templates for generation of the MD145 and Urbana (URB) feline
mic RNA and Mg2+. 5 μl of each reaction were directly analyzed by SDS-PAGE
toradiography (panel I). rVPg-His (lanes 1 to 3 and 7 to 10) and rHis-Y27A/VPg
s were conducted in the presence of FL genomic RNA (lanes 1 to 6 and 10) or a
Pg and oligo(U) were tested, and they are indicated above panel I. For the negative
n assay in the presence of FL genomic RNA. Immunoprecipitated rVPg-His is
Pg (lanes 8 to 14) were assayed for uridylylation in the presence of 1 to 5 μg of
ngORF3 (FL-NcoI, lanes 3 and 10), genomicRNA (FL, lanes 4 and 11), poly(A)n
egative control, VPg was assayed in the absence of Mg2+ (lanes 7 and 14). 5 μl of
dicated by arrows. Panel II. Wild type rVPg-His was assayed for uridylylation in
orovirusMD145 (lanes 1–6) or feline calicivirus (FCV)Urbana (lanes 8 and 9) as
enger RNA (Life Technologies, Gaithersburg, Maryland) was included as a non-
late RNA from the uridylylation reaction mixture.
Fig. 7 (continued ).
43G. Belliot et al. / Virology 374 (2008) 33–49Our data suggested that the FL genomic RNA transcript
might contain an element(s) that enhanced the uridylylation of
VPg in the presence of Mg2+. To further investigate this
possibility, additional RNA transcripts derived from linearized
cDNA clones and corresponding to various regions of the
MD145 genome (Fig. 7A) were each added to a uridylylation
reaction containing rVPg-His or rHis-Y27A/VPg and Mg2+ as
the divalent cation (Fig. 7C). As shown above, the rVPg-His
recombinant protein was uridylylated in the presence of a poly-
adenylated FL genomic RNA transcript (Fig. 7C, lane 4, panel I)
and of interest, it was efficiently uridylylated in the presence of a
polyadenylated MD145 subgenomic RNA that contained ORFs
2 and 3 and the 3'-end nontranslated region (Fig. 7C, lane 1,
panel I). The VPg was not uridylylated in the presence of RNA
corresponding to the FLMD145 ORF1 (Fig. 7C, lane 2, panel I),
a truncated FL genome transcript lacking 890 nucleotides fromthe 3'-end and the poly(A) tail (FL-NcoI) (Fig. 7C, lane 3,
panel I), or a poly(A) template (Fig. 7C, lane 5, panel I). These
data suggested that the enhanced nucleotidylylation activity in
the presence of the polyadenylated FL genomic and subgenomic
MD145 RNA transcripts was sequence-dependent, and not due
to a nonspecific activity in the template preparations or a con-
taminating non-viral RNA. The VPg was not efficiently
uridylylated in the absence of RNA with Mg2+ as the divalent
cation (Fig. 7C, lane 6, panel I) or when Tyr 27 was mutagenized
to alanine (Fig. 7C, lanes 8–14, panel I).
To further investigate the location and specificity of a po-
tential CRE-like structure involved in the uridylylation of the
VPg protein, we designed and generated T7 promoter-bearing
PCR products that would allow the transcription of RNA mole-
cules corresponding to selected regions of the MD145 and
feline calicivirus genomes (Table 1 and Fig. 7A). In addition,
Table 1
Oligonucleotides used for the site-directed mutagenesis of the pET constructs and for generating RNA transcripts
Generated construct Template Oligonucleotide sequences a, f
pET-His-Y27A/VPg pET-His-VPg GTGATGAAGAGGCCGATGAGTACAAG
pET-His-Y30A/VPg pET-His-VPg GAGTACGATGAGGCCAAGAGAATCAG
pET-His-Y41A/VPg pET-His-VPg GAAACGGCAAGGCCTCCATAGAAG
pET-His-Y46A/VPg pET-His-VPg CCATAGAAGAGGCCCTTCAGGACAG
pET-His-Y53A/VPg pET-His-VPg GACAGGGACAAGGCCTATGAGGAGGTG
pET-His-Y54A/VPg pET-His-VPg GGGACAAGTACGCTGAGGAGGTGGC
pET-His-Y27,30A/VPg b pET-His-Y27A/VPg Y27,30A: GAGgcCGATGAGGCCAAGAGAATCAG
pET-His-Y27,41A/VPg pET-His-Y27A/VPg GAAACGGCAAGGCCTCCATAGAAG
pET-His-Y27,46A/VPg pET-His-Y27A/VPg CCATAGAAGAGGCCCTTCAGGACAG
pET-His-Y27,53A/VPg pET-His-Y27A/VPg GACAGGGACAAGGCCTATGAGGAGGTG
pET-His-Y27,54A/VPg pET-His-Y27A/VPg GGGACAAGTACGCTGAGGAGGTGGC
pET-His-Y27,46,53,54A/VPg c, d pET-His-Y27,46A/VPg Y53,54A: GAGgcCCTTCAGGACAGGGACAAGGCCGCTGAGGAGGTGGCCATTGCCAGGGCG
pET-His-Y27,30,41,46,53,54A/VPg b, c, e pET-His-Y27,46,53,
54A/VPg
Y41,46A: GAAGAAAGAAACGGCAAGGCCTCCATAGAAGAGgcCCTTCAGGACAGGGAC
Y27,30A: GAGgcCGATGAGGCCAAGAGAATCAG
MD145/SG and MD145/SG-(A)29 pSPORT1-FL/MD145 AATTCGTCTCACTGGTAATACGACTCACTATAGGTGAATGAAGATGGCGTCGAGTGACGCCAACCCATC
MD145/SG 5'Δ24 and
MD145/SG 5'Δ24-(A)29
pSPORT1-FL/MD145 AATTCGTCTCACTGGTAATACGACTCACTATAGCGCCAACCCATCTGATGGGTCCGCAGCCAACCTCGTCCCAGAGG
MD145/ORF3-3'NTR and
MD145/ORF3-3'NTR-(A)29
pSPORT1-FL/MD145 AATTCGTCTCACTGGTAATACGACTCACTATAGATGGCTGGATCTTTCTTTGCTGGATTGGCATCTGATGTCC
MD145/SG-(A)29 and
MD145/ORF3-3'NTR-(A)29
pSPORT1-FL/MD145 TTTTTTTTTTTTTTTTTTTTTTTTTTTTTAAAAGACACTAAAGAAGAGAAAGAAAATCAATTTTGTCTTTTC
MD145/SG pSPORT1-FL/MD145 AAAAGACACTAAAGAAGAGAAAGAAAATCAATTTTGTCTTTTC
FCV/URB SG and FCV/URB SG-(A)29 pQ14 AATTCGTCTCACTGGTAATACGACTCACTATAGGTTTGAGCATGTGCTCAACCTGCGCTAACGTGCTTAAATATTATAATTGG
FCV/URB SG pQ14 CCCTGGGGTTAGGCGCAAATGCGGCAGCCCAAAGGGATACTTGTG
FCV/URB SG-(A)29 pQ14 TTTTTTTTTTTTTTTTTTTTTTTTTTTTTCCCTGGGGTTAGGCGCAAATGCGGCAGCCCAAAGGGATACTTGTG
a Only the positive-sense oligonucleotide is shown for the pET constructs. Nucleotides substitutions are underlined.
b Mutagenized sequence corresponding to Y27A is indicated in lower case (primer Y27,30A).
c Mutagenized sequence corresponding to Y46A is indicated in lower case (primers Y41,46A and Y53,54A).
d Primer set Y53,54A was used to generate the plasmid intermediate construct pET-His-Y27,46,53,54A/VPg (not assayed), using pET-His-Y27,46A/VPg as template.
e Primer sets Y41,46A and Y27,30A were used together to mutagenize intermediate template construct pET-His-Y27,46,53,54A/VPg to produce final construct pET-His-Y27,30,41,46,53,54A/VPg.
f Non-viral sequences which include a T7 promoter are indicated in bold.
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45G. Belliot et al. / Virology 374 (2008) 33–49we examined a potential role for the poly(A) tail by engineering
viral RNA molecules with and without a poly(A) tract and by
including a polyadenylated cellular RNA control (beta-
globulin) (Fig. 7C, panel II, lane 7). Transcripts corresponding
to the predicted full-length MD145 subgenomic RNA (nt 5081–
7556 of the genome), a 5-'end truncated subgenomic RNA (nt
5105–7556 of the genome,) and an ORF2-truncated RNA
(bearing the ORF3 and 3'-end NTR) were each added to a VPg
uridylylation reaction that was performed in the presence of
Mg2+ (Fig. 7C, panel II, lanes 1 to 6). The addition of each of
these three polyadenylated MD145 subgenomic RNA deriva-
tives increased the efficiency of uridylylation in the presence of
Mg2+ (Fig. 7C, panel II, lanes 1, 3, and 5), but those lacking a
poly(A) tail did not (Fig. 7C, panel II, lanes 2, 4, and 6). The
addition of a full-length subgenomic RNA (with or without a
poly(A) tail) corresponding to the genome of the Urbana (URB)
strain of FCV (nt 5306–7683) (Fig. 7C, panel II, lanes 8 and 9)
or a polyadenylated cellular RNA (Fig. 7C, panel II, lane 7) did
not enhance uridylylation of the VPg. Taken together, these data
suggest that an element located near the 3'-end of the MD145
viral RNAwas associated with the efficient uridylylation of the
VPg protein in the presence of Mg2+. The fine mapping and
specificity of this enhancing element will require further study.
Discussion
VPg proteins are covalently-linked to the RNA genomes of
viruses in the families Caliciviridae (Dunham et al., 1998),
Picornaviridae (Ambros and Baltimore, 1978; Rothberg et al.,
1978), Nepoviridae (Daubert et al., 1978; Stanley et al., 1978;
Zalloua et al., 1996), Comoviridae (Jaegle et al., 1987) and
Potyviridae (Murphy et al., 1990, 1991; Oruetxebarria et al.,
2001). The sizes and the functions of VPg proteins vary.
Calicivirus genomes possess a 5'-end-linked VPg protein that
has been implicated in both translation and replication
(Daughenbaugh et al., 2003; Goodfellow et al., 2005; Mitra
et al., 2004; Rohayem et al., 2006b). This study focused on the
characterization of the nucleotidylylation reaction that would
link covalently the norovirus VPg to a nucleotide, presumably
the first step in the attachment of VPg to the RNA genome and
the initiation of RNA synthesis by the RdRp on an RNA
template. In this study, we demonstrate that the norovirus VPg
can be nucleotidylylated by the ProPol form of the norovirus
RdRp in a template-independent reaction when Mn2+ is the
divalent cation. Our data showed that the presence of a His-
tag on the VPg protein did not have a deleterious effect on
nucleotidylylation, and various forms of recombinant norovirus
RdRp including rPro–Pol, rHis-Pro–Pol and rHis-E1189A/
ProPol had similar activities. Uridylylation assays, conducted in
the presence of a poly(A) template, resulted in an increase in the
uridylylation of VPg, and in apparent de novo synthesis of poly
(U) molecules by a possible copy-back mechanism. Our results
and a previous study (Rohayem et al., 2006b) suggested that
VPg, if functioning as primer, might be covalently-linked to
nascent poly(U) molecules. However, our RIPA experiments
(Fig. 6C) indicated that the VPg was uridylylated, but not
covalently-linked to the newly-synthesized radiolabeled RNAproducts. Similar observations were made in our analysis of the
nucleotidylylation of VPg in the presence of MD145 FL RNA
and Mg2+ (Fig. 7B), in which we could not show evidence for
covalent linkage to the newly-synthesized RNA products gen-
erated in vitro. It will be important to verify whether nucleo-
tidylylated VPg is performing a priming function in calicivirus-
infected cells as suggested recently (Rohayem et al., 2006b), or
is simply part of the mechanism by which the VPg becomes
linked to the viral RNA so that it can function in translation.
Similarities of the calicivirus nucleotidylylation reaction
with those of other positive strand RNA viruses with VPg
proteins such as the picornaviruses and potyviruses include the
utilization of tyrosine as the site of RNA linkage in the VPg. We
mapped tyrosine 27 of the MD145 norovirus VPg as the site of
this linkage, which is conserved among the caliciviruses. The
nucleotidylylation reaction of the MD145 VPg was template-
independent in the presence of Mn2+, and was not specific for
any one nucleotide. Similar observations have been reported in
studies of the VPg proteins of RHDV and potyvirus (Machin
et al., 2001; Puustinen and Makinen, 2004). Although our data
showed that the NoV VPg could be linked to any of the four
nucleotides, GTP and UTP were the preferred bases. Interest-
ingly, a recent study showed that NoV Pol initiated RNA syn-
thesis with only GTP and UTP in the presence of poly(C) and
poly(A) homopolymeric templates, respectively (Rohayem
et al., 2006b). In the same study, the authors reported that
uridylylation of the VPg protein in the presence of Mn2+ by Pol
was strictly template-dependent (Rohayem et al., 2006b), which
differed from our findings. Structural differences between Pol
and ProPol might explain the variation in the requirement for a
poly(A) template in uridylylation when Mn2+ is the divalent
cation. The presence of Mn2+ in the reaction might induce a more
relaxed conformation of the ProPol polymerase as suggested
previously for RHDV Pol (Machin et al., 2001).
Our study demonstrated that the ProPol form of the
norovirus RdRp can mediate nucleotidylylation of the VPg,
consistent with our previous studies showing that the norovirus
RdRp is enzymatically active as a precursor protein (ProPol) or
in its cleaved form (Pol) (Belliot et al., 2005). The MD145
ProPol and RHDV Pol behaved similarly in in vitro uridylyla-
tion assays in that the reaction was template-independent in the
presence of Mn2+, the preferred divalent cation (Machin et al.,
2001). The similarities in nucleotidylylation requirements be-
tween the ProPol and Pol forms of the RdRp from members of
two distinct calicivirus genera suggest that both forms may have
the capacity to mediate nucleotidylylation during virus replica-
tion. In MNV or in Norwalk virus replicon-bearing cells, the
cleaved Pol form of the RdRp is predominant (Chang et al.,
2006; Sosnovtsev et al., 2006), whereas in FCV- or RHDV-
infected cells the ProPol form is predominant (Konig et al.,
1998; Sosnovtsev et al., 2002). Although the abolition of the
cleavage site between the Pro and Pol domains was recently
shown to be lethal for MNV (Ward et al., 2007), it does not rule
out a role for a transient form of the NoV ProPol precursor in
the modification of VPg during replication. It will be of interest
in future studies to examine whether the ProPol precursor
plays a specific role in nucleotidylylation during replication,
46 G. Belliot et al. / Virology 374 (2008) 33–49and whether cellular factors or membranes are involved in this
reaction. It should be noted that Pro and Pol domain of 3CDpro
were shown to interact with the CRE of human rhinovirus 14
(Yang et al., 2004). It is possible that similar interactions occur
in the noroviruses, but additional studies will be needed to map
these interacting domains.
The mutagenesis analysis in this study provided evidence for
the importance of structural requirements in the norovirus VPg.
First, the N-terminal region of the VPg was required for
efficient nucleotidylylation of the VPg. This region is rich in
lysine residues, and similar to an NTP-binding motif in the
potyvirus (potato A virus) VPg. It is possible that the N-
terminus of the norovirus VPg might facilitate nucleotidylyla-
tion by recruitment of NTPs. Alternatively, the ablation of this
region might simply disrupt the conformation of the site of
nucleotidylylation at Tyr 27, affecting its presentation to the
RdRp. The second observation was an enhancement of nucleo-
tidylylation at Tyr 27 when the nearby tyrosine at residues 30,
41, or 46 was mutated to alanine. Because there is presently no
reverse genetics system for the human noroviruses, it is difficult
to assess the biological relevance of these mutations. However,
a study using the FCV reverse genetics system showed that the
mutation of tyrosine at positions other than 24 (residues 12, 76
or 104) were not lethal to the virus (Mitra et al., 2004). It will be
interesting to examine whether mutations of the tyrosine
residues at positions 30, 41 or 46 of the MD145 VPg might
actually increase the level of nucleotidylylation of the VPg
protein during replication and affect viral growth.
We report in this study the first evidence for the presence of an
RNA sequence element in the 3'-end region of the norovirus
genome that could specifically and markedly enhance nucleoti-
dylylation of the VPg by the RdRp in the presence of Mg2+. The
nucleotidylylation was NoV-specific and required the presence of
poly(A)-tailed NoV RNA molecules. It is not yet clear whether
this element is analogous to the CRE structure of picornaviruses.
Of interest, deletional mutagenesis of the FCV genome showed
evidence for the importance of sequences near the 3'-end of the
genome in viral replication (Sosnovtsev et al., 2005). It is possible
that a CRE-based system for nucleotidylylation might help the
calicivirus replication machinery distinguish between viral and
cellular messenger RNAs. Additional studies will be required to
verify whether a CRE-like structure is present in the 3'-end of
norovirus genomes, and functions during replication in cells.
Replicon (Chang et al., 2006) and rescue systems (Chaudhry
et al., 2007; Ward et al., 2007) which have been published for
human NoVand MNV, respectively, are promising tools to study
the replication mechanisms of these viruses.
Materials and methods
Viruses and materials
Norovirus strain MD145-12 (Hu/NoV/GII.4/MD145-12/
1987/US) was described previously (Green et al., 2002), and
the sequence of the viral genome was assigned GenBank
accession number AY032605. Oligonucleotide primers were
purchased from Invitrogen (Carlsbad, CA). [α-32P]-labelednucleotides UTP, GTP, ATP or CTP at 400 Ci/mmol and
[γ-32P]-GTP at 400 Ci/mmol were purchased from Amersham
(Piscataway, NJ).
Plasmids and mutagenesis
A cDNA copy of the FL genomic or predicted subgenomic
RNA of the MD145 norovirus strain was cloned into theΔlacα/
T7-pSPORT1 vector (Belliot et al., 2003) so that the T7
promoter was engineered immediately upstream of the 5'-end.
Briefly, two overlapping fragments corresponding to nucleotides
(nt) 3398 through 5419 and nt 5419 through the 3'-end of the FL
genome were amplified by RT-PCR and cloned into the vector
pCR2.1 using the TOPO cloning system (Invitrogen). The frag-
ment corresponding to positions 3393 through 5419 (amplified
by RT-PCR with the forward primer 5'-CAAATGGGCATGC-
TTCTGACAGGATC-3' and the reverse primer 5'-CGGTGAA-
CGCGTTCCCCGCGAGGATTAC-3' with an engineered MluI
site, underlined) was excised from the pCR2.1 vector with
BamHI and MluI and cloned into the corresponding sites of the
previously described plasmid cORF1 (Belliot et al., 2003). The
resulting construction was named T7-frag-I+II+III+IV+V. The
fragment corresponding to the position 5419 through the 3'-end
of the viral genome was amplified by RT-PCR using the forward
primer 5'-GTAATCCTCGCGGGGAACGCGTTCAC-3' (MluI
site underlined) and the reverse 3'-end primer 5'-GCGGAC-
GTC(T)30AAAAGACAC-3' with an engineered poly(A) tail of
30 nucleotides (bold type) and an AatII restriction site (under-
lined) and cloned into pCR2.1 to generate an intermediate con-
struct designated TOPO-frag VI+VII. TOPO-frag VI+VII and
the construct T7-frag-I+II+III+IV+V were digested with MluI
and AatII and ligated together. The final construction (desig-
nated FL/MD145-12) contained the FL genome of the MD145-
12 norovirus strain with a poly(A) tail of 30 nucleotides at the
3'-end. For the subgenomic cDNA clone, the fragment corre-
sponding to position 6831 through the poly(A) tract at the 3'-end
of the viral genome was amplified by RT-PCR using the forward
primer 5'-AACTGCAGTAATACGACTCACTATAGTGA-
ATGAAGATGGCGTCGAGTG-3' (the PstI site is underlined
and the T7 promoter is in bold type) and the reverse 3'-end primer
described above. The PCR fragment was cloned into the pCR2.1
vector and the intermediate plasmid construct was named TOPO-
SG. The construct TOPO-SG was treated with PstI and HindIII
and the fragment of interest containing the first 1778 bp of the 5'-
end of the subgenomic cDNA was gel-purified prior to ligation
into PstI/HindIII-treated ΔT7-pSPORT1. The resulting plasmid
was named pSPORT-5'regSG. For the cloning of the 3'-end of the
subgenomic cDNA, the plasmid constructs TOPO-SG and
pSPORT-5'regSG were both treated by HindIII and AatII. A
fragment of 752 bp representing the 3'-end of the subgenomic
RNA was gel-purified and ligated with pSPORT-5'regSG to
generate the final construct pSPORT1-SG. The plasmid con-
struct pSPORT1-SG contained the cDNA of the FL subgenomic
RNA under the control of a T7 promoter, and a poly(A)30 tract at
the 3'-end. The selected genomic and subgenomic clones were
shown by sequence analysis to represent the consensus sequence
of the viral RNA genome.
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proteins is shown in Fig. 1A. All constructs were generated using
the cORF1 construct as template, and verified by sequencing
analysis. The constructs pET-VPg, pET-Pro, pET-His-Pro–Pol
and pET-His-E1189A/ProPol were previously described (Belliot
et al., 2005, 2003).
The fragment corresponding to the VPg coding sequence
was amplified by PCR with the forward primer 5'-CATGC-
CatgGGCAAGAAAGGGAAGAACAAGACTGGCCG-3'
which included aNcoI site (underlined), a start codon (lowercase),
and the reverse primer 5'-AAGGAAAAAAGCGGCCGCt-
caGTGGTGGTGGTGGTGGTGCTCAAAACTGAGTCT-3'
which included a NotI site (underlined), a stop codon (lowercase),
and a His-tag-encoding sequence (bold type). The fragment was
digested with NcoI and NotI and cloned into the corresponding
restriction enzyme sites of the pET-28(b) vector (Novagen,
Madison, WI) to generate pET-VPg-His. pET-VPg-His was used
as the template to generate the plasmid constructions pET-Δ3-
VPg-His, pET-Δ8-VPg-His and pET-Δ20-VPg-His by using
PCR amplicons produced with the forward primers 5'-CATG-
CCatgGGGAAGAACAAGACTGGCCGTGG-3' (Δ3), 5'-
CATGCCatgGGCCGTGGCAAGAAGCACACAGC-3' (Δ8),
5'-CATGCCatgGGTCTCAGTGATGAAGAGTACGATGAG-
3' (Δ20) (start codon is in lowercase and NcoI site is underlined),
respectively, and the reverse primer used to engineer pET-VPg-
His.
The plasmid pET-VPg, described previously (Belliot et al.,
2003), was used as template for site-directed mutagenesis
(QuikChange kit; Stratagene, La Jolla, CA) of the Tyr codons at
positions 27, 30, 41, 46, 53 and 54 of the VPg protein (Fig. 1A)
intoAla residues, to produce the DNA constructs pET-His-Y27A/
VPg, pET-His-Y30A/VPg, pET-His-Y41A/VPg, pET-His-
Y46A/VPg, pET-His-Y53A/VPg and pET-His-Y54A/VPg,
respectively. The plasmid construction pET-His-Y27A/VPg was
used as template to produce the double-mutated VPg DNA con-
structs pET-His-Y27,30A/VPg, pET-His-Y27,41A/VPg, pET-
His-Y27,46A/VPg, pET-His-Y27,53A/VPg, and pET-His-Y27,
54A/VPg. To produce the DNA construct pET-His-Y27,30,41,
46,53,54A/VPg, the construct pET-His-Y27,46A/VPg was se-
quentially mutagenized to produce the intermediate construct
pET-His-Y27,46,53,54A/VPg, which was then used as template
to obtain the final construct pET-His-27,30,41,46,53,54A/VPg.
Primers used in the VPg mutagenesis experiments are shown in
Table 1. All mutagenized VPg constructs were verified by se-
quencing analysis.
The SUMO expression system (LifeSensors, Malvern, PA.)
was used to produce and purify recombinant MD145 VPg that
would represent the native protein without a His-tag. The plasmid
pET-VPg was employed as template for the PCR amplification of
the VPg coding sequence with the forward primer 5'-AAGGA-
AAAAACGTCTCAAGGTGGCAAGAAAGGGAAGAACAA-
GACTGG-3' (theBsmBI site is underlined) and the reverse primer
5'-AAGGAAAAAAGCGGCCGCTCACTCAAAACT-
GAGTCTCTCATTGTAGTC-3' (the NotI site is underlined). The
resulting DNA fragment was treated with BsmBI andNotI prior to
ligation into the BsaI and NotI sites of the pSUMO plasmid. The
final construct, designated pSUMO-VPg, was engineered toexpress the VPg protein fused at its N-terminus to a His-tagged
SUMO peptide (Fig. 1B). A cleavage site for the SUMO-specific
ubiquitin-like protease (Ulp1) was incorporated into the C-
terminus of the SUMO peptide. Cleavage of the SUMO-VPg
fusion protein by the SUMO-specific Ulp1 proteinase released the
VPg with its precise N-terminus and the efficiency of the cleavage
was monitored by SDS-PAGE analysis. The plasmid pSUMO-
VPgwas used as template for site-directedmutagenesis to produce
the plasmids pSUMO-Y27A/VPg and pSUMO-Y30A/VPg. The
primers used for themutagenesis are described above for theDNA
constructs pET-His-Y27A/VPg and pET-His-Y30A/VPg.
Protein synthesis and purification
pET- and pSUMO-related constructs were used to transform
E. coli BL21(DE3) cells (Novagen). The protein expression and
purification protocols were previously described (Belliot et al.,
2005). Briefly, all recombinant VPg proteins were character-
istically found in the soluble fraction of E. coli BL21(DE3) cells
following induction of expression with 1 mM IPTG (Isopropyl
β-D-1-thiogalactopyranoside). The recombinant proteins were
bound to a Ni-NTA column and eluted with buffer (300 mM
NaCl, 50mMNaH2PO4, 10% glycerol, pH 8) containing 60mM
imidazole. The recombinant proteins His-VPg, VPg-His, His-
Y27A/VPg, His-Y30A/VPg, His-Y41A/VPg, His-Y46A/VPg,
His-Y453A/VPg, His-Y54A/VPg, His-Y27,30A/VPg, His-
Y27,41A/VPg, His-Y27,46A/VPg, His-Y27,53A/VPg, His-
Y27,54A/VPg, His-Y27,30,41,46,53,54A/VPg, Δ3-VPg-His,
Δ8-VPg-His, Δ20-VPg-His, Pro, His-Pro–Pol and His-E1189A/
ProPol were dialyzed overnight at 4 °C against 150 mM KCl,
50 mM Tris pH 8, 2 mM DTT and 20% glycerol, aliquoted, and
stored at −80 °C. The recombinant proteins rVPg-His, rΔ3VPg-
His, rΔ8VPg-His and rΔ20VPg-His, in which the His-tag was
engineered at the C-terminus, were analyzed by direct N-
terminal sequencing using the Edman degradation method.
Although an initiating methionine had been engineered at the
beginning of each protein, only the rVPg-His retained the
methionine residue following expression and purification. The
truncated proteins began at the expected amino acid residues 4
(rΔ3VPg-His), 9 (rΔ8VPg-His) and 21 (rΔ20VPg-His). The
proteins His-SUMO-VPg, His-SUMO-Y27A/VPg and His-
SUMO-Y30A/VPg were dialyzed overnight at 4 °C against
PBS pH 7.4, 10% glycerol and 2 mM DTT. To remove the
SUMO tag, the purified fusion proteins were diluted to 1 mg/ml
and incubated with His-tagged Ulp1 (1 U/20 μg) (Life Sensors,
Inc.) at 4 °C, overnight. The protein mixture was then diluted to
a final volume of 2 ml with a binding buffer containing 300 mM
NaCl, 50 mMNaH2PO4 (pH 8) and 10% glycerol. Two hundred
fifty microliters of Ni-NTA resin slurry (Qiagen, Valencia, Calif)
at 50% (vol:vol) were added to the mixture and incubated for 1 h
at 4 °C. The mixture was centrifuged at 10,000 ×g for 10 min
after the incubation and the supernatant containing the purified
tag-free recombinant protein (rVPg, rY27A/VPg and rY30A/
VPg) was collected. The volume of the supernatant was reduced
to 1 ml by using a 10 kDa-cutoff Centricon column (Millipore,
Bedford MA) that was centrifuged twice at 3000 ×g for 45 min.
The concentrated proteins were dialyzed overnight at 4 °C
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20% glycerol. The dialyzed protein was concentrated further
with a 10 kDa-cutoff Microcon column (Millipore) that was
centrifuged twice at 10,000 ×g for 30 min. The protein quantity
was measured by using the Bradford method and the proteins
were stored at −80 °C.
Nucleotidylylation assay
The nucleotidylylation assay was adapted from Machin et al.
(2001) and carried out for 3 h at 30 °C in a 15 μl reaction
mixture containing 50 mM HEPES, 10 mM DTT, 0.5 or 1 mM
MnCl2, 67 μM ZnCl2, 10 μM NTP (GTP, UTP, CTP or ATP),
5 μCi [α-32P] NTP (GTP, UTP, CTP or ATP) or [γ-32P]-GTP,
1 μg of rHis-Pro–Pol, rE1189A-ProPol or tag-free rPro–Pol
(Belliot et al., 2005) and 0.5 to 3 μg of rHis-VPg. 5 μl of the
reaction was resolved by SDS-PAGE, unless indicated.
For nucleotidylylation assays in the presence of heteropoly-
meric RNA templates, RNA transcripts corresponding to the
norovirus strain MD145 FL genomic and subgenomic RNAs
were synthesized either fromAatII-linearized plasmid constructs
or PCR fragments using a Ribomax kit (Promega) with T7
polymerase according to the manufacturer's protocol. Following
DNAse treatment, transcripts derived from PCR products were
further purified with theMEGAclear kit (Ambion). The integrity
of all transcribed RNA (following quantification) was monitored
by gel electrophoresis. A typical reaction contained 50 mM
HEPES, 10 mM DTT, 5 mM MgCl2, 67 μM ZnCl2, 50 mM
potassium acetate, 30 μM of each NTP (GTP, UTP, CTP or
ATP), 15 μCi [α-32P] UTP, 2.5 μg of rHis-E1189A/ProPol,
2.5 μg of rVPg-His or rHis-Y27A/VPg, and 1 to 5 μg of
heteropolymeric RNA or poly r(A)n. The assay was carried out
in a 25 μl reaction mixture for 3 h at 30 °C. Following the assay,
themixture was heated at 95 °C for 5min, and 5 μl of the reaction
were analyzed by SDS-PAGE. In some experiments, the re-
maining reaction mixture was analyzed in a RIPA (see below).
Enzymatic treatment of VPg
[32P]-labeled uridylylated VPg was dialyzed against 1000
volumes of buffer containing 50 mM NaCl, 50 mM Tris–HCl
(pH 8.0) before it was subjected to treatment with proteinase K
(0.5 mg/ml, Invitrogen), CIAP (500 U/ml, Invitrogen), or RNase
(25 μg/ml, Roche) according to protocols recommended by the
manufacturers. For P1 treatment [α32P]-labeled RNase-treated
VPg was dialyzed against P1 reaction buffer (0.2 mM ZnCl2,
2 mM MgCl2, 50 mM Na acetate, pH 5.3) and then was treated
with P1 nuclease (MP Biomedicals, Solon, Ohio) at 0.5 U/1 μg
of VPg for 1 to 3 h at 37 °C. For PDE1 treatment, the P1
nuclease-treated VPg was dialyzed against 1000 volumes of
buffer containing 50 mM NaCl, 50 mM Tris–HCl (pH 8.0) and
then against 1000×volumes of 0.5×PDE1 reaction buffer
(0.05 M Tris–HCl pH 8.9, 0.05 M NaCl, 7.5 mM MgCl2). The
VPg solution was adjusted to 0.11 M Tris–HCl (pH 8.9), 0.11M
NaCl, 15 mM MgCl2 (1×PDE1 buffer) using 2× PDE1 buffer
and digestion with PDE1 (Worthington, 0.5 U/1 μg of VPg) was
performed at either 25 °C or 37 °C for 1 to 3 h.Following all enzymatic treatments, the VPg was subjected
to SDS-PAGE analysis (see below). The integrity of the protein
was determined by visualization with Coomassie blue (Gel-
code Blue Stain Reagent from Pierce, Rockford, IL), after
which the gel was dried and subjected to autoradiography with
X-Omat AR film (Kodak, Rochester, NY).
Protein electrophoresis and immunoprecipitation assay
Nucleotidylylation assay products were analyzed by SDS-
PAGE on a 4–12% polyacrylamide gel (NUPAGE system from
Invitrogen) with 1XMOPS running buffer (Invitrogen), unless
indicated. The proteins were stained with Gel-code Blue Stain
Reagent, after which the gel was dried and exposed to film. To
estimate the amount of NMP incorporated into VPg, the band
corresponding to VPg was excised, placed in 5 ml liquid scin-
tillation fluid (ICN, Costa Mesa, CA), and the radioactivity was
counted using a Wallac 1409 liquid scintillation counter (Perkin-
Elmer). Radiolabeled-mutated VPg proteins (rHis-Y/A-VPg) were
also analyzed with a Phosphorimager (Molecular Dynamics) and
the IP Lab Gel suite (SignalAnalytics, Vienna, VA).
The MD145 VPg-specific antiserum (post-immunization),
used in the RIPA, was prepared in guinea pigs as described
previously (Belliot et al., 2003). Serum from the animal col-
lected before immunization (pre) served as a control for anti-
body specificity.
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